ASIC Ategrity delivers 299 percent EPS beat and 234 percent year over year revenue growth in Q4 2025 Is Rigel Pharmaceuticals RIGL stock cheap relative to earnings growth Rigel Pharmaceuticals misses EPS estimates by 96 Intrusion INTZ Stock Is It a Smart Buy Q4 2025 Below Expectations Julong JLHL Stock Valuation Kezar Life KZR Stock Reasonably Valued Volatility Increases 20260420 High PCF Stock Support and Resistance Zones Calamos CSQ Stock Support and Resistance Neutral 20260420 SMXT Solarmax Technology Q4 2025 revenue rises 296 percent year over year shares climb nearly 4 percent Fox Corporation FOX IMXI International Q4 2025 earnings miss estimates on 77 percent annual revenue drop shares edge higher today Is BioCardia BCDA stock influenced by uncertainty BioCardia Posts 654 EPS Beat With No Q4 Revenue Gentherm THRM Stock Slides 003 20260420 CIG Cemig posts blowout Q4 2025 earnings on seven percent revenue growth shares gain over two percent